
Tilray (TLRY) shares are ripping higher on Monday after a senior Jefferies analyst issued a positive note in favor of the cannabis specialist.
Kaumil Gajrawala maintained his “Buy” rating on the New York-headquartered firm and raised his price target to $2, indicating potential upside of another 50% from current levels.